Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Drug Manufacturing / Generics
sawai.co.jp

Investments

2

Portfolio Exits

1

Partners & Customers

2

About Sawai Pharmaceutical

Sawai Pharmaceutical (TYO: 4555) is a Japanese generic pharmaceuticals manufacturer. Sawai focuses on the manufacturing and sales, export and import of generic pharmaceutical products.

Headquarters Location

5-2-30 Miyahara, Yodogawa-ku

Osaka, 532-0003,

Japan

+81 06-6105-5711

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Sawai Pharmaceutical News

22:45 EDT Testosterone replacement therapy market to grow by USD 439.67 million between 2022 and 2027; Growth driven by initiati...

May 3, 2023

News provided by Share this article Share this article NEW YORK, May 2, 2023 /PRNewswire/ -- The testosterone replacement therapy market  size is forecast to increase by USD 439.67 million from 2022 to 2027, at a CAGR of 3.38%, according to the recent market study by Technavio. The growth of the market will be driven by the initiatives to increase awareness about hypogonadism among the population, rising chronic diseases, and the increasing aging population and postmenopausal women. Charts & data tables about market and segment sizes for a historic period (2017-2021) and forecast period (2023-2027) have been covered in this report. Download The Sample Report Vendor Analysis The global testosterone replacement therapy market is fragmented, with many small-to-large-scale vendors. Key vendors hold significant shares in the market. Established vendors have strong financial abilities and technical expertise in offering safer and more effective products. The established vendors are deploying a significant share of their capital in product R&D and are focusing on adopting organic growth strategies such as product launches to bring considerable differentiation in their products and gain higher customer penetration. The small-scale vendors are competing with the established vendors by using low-price strategies and strengthening their local customer base. The market is likely to remain dominated by some of the prominent large-scale vendors that offer US FDA-approved and renowned testosterone replacement therapy drugs during the forecast period. Some of the key vendors covered in the report include: AbbVie Inc. - The company offers testosterone replacement therapy such as Androderm. Acerus Pharmaceuticals Corp. - The company offers testosterone replacement therapy such as Natesto. Alembic Pharmaceuticals Ltd. - The company offers testosterone replacement therapy such as gel with 20.25 mg and 1.25 gm actuation. Amneal Pharmaceuticals Inc. - The company offers testosterone replacement therapy such as CIII gel for topical use. Actiza Pharmaceutical Pvt. Ltd. Analyse the data and grow your profit margin with Technavio - Buy the Report Key Benefits for Industry Players & Stakeholders – The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology. It also provides detailed analyses of the market's competitive landscape and vendors' product offerings. The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak. Get a holistic overview of the testosterone replacement therapy market to develop growth strategies. Download the Sample Market Segmentation: The market is segmented by distribution channel (hospitals, retail, and online), product (injectables, topicals, and others), and geography (North America, Europe, Asia, and Rest of World). The market growth in the hospitals segment will be significant over the forecast period. Hospital pharmacies provide advice on drug dosages, interactions, and potential side effects, as well as monitor patient adherence to medication regimes. This helps in improving patient outcomes. Hospital pharmacies also assist in clinical trials to test the safety and efficacy of new drugs. As a result of these factors, the hospital pharmacy segment is expected to dominate the market growth during the forecast period. North America will account for 57% of the market growth during the forecast period. The growth of the regional market is driven by the strong presence of key vendors and the easy availability of new and improved products. The increasing cases of hypogonadism and rising awareness about the treatment of testosterone deficiency and erectile dysfunction are other factors driving the growth of the testosterone replacement therapy market in North America. Market Dynamics: The rise in chronic diseases Increasing aging population and postmenopausal women Many organizations are working on increasing patient awareness regarding hypogonadism and available treatment options. For instance, Endocrine Society has undertaken various initiatives to increase awareness about hypogonadism among medical professionals. It has released clinical practice guidelines on testosterone therapy, which helps in the safer delivery and reduction of adverse events. Similarly, organizations such as the Testicular Cancer Awareness Foundation, Endocrine Awareness Center for health, and the AUA are educating the population about the diagnosis and treatment of hypogonadism. Such awareness programs have led many patients to proactively approach fertility care centers and medical practitioners to undertake testosterone replacement therapy. All these factors are driving the growth of the market. Major Trends: Patient assistance programs Growing new developments in the market The market has witnessed a rise in the number of novel therapies to treat testosterone deficiency. Vendors in the market are increasing their R&D efforts to develop alternative treatment options that can ensure safe use during testosterone replacement therapies. The growing focus of vendors toward such therapeutic approaches is expected to contribute to the launch of new drugs. For instance, at the Endocrine Society's annual meeting, Dr. Fahim Ebrahimi presented the results of a recent study that analyzed the therapeutic effects of Anakinra on testosterone levels. According to the study, testosterone levels rose by 11% in the treatment group. Such developments are expected to foster the growth of the market during the forecast period. Key Challenges: CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the testosterone replacement therapy market between 2023 and 2027 Precise estimation of the size of the testosterone replacement therapy market and its contribution to the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the testosterone replacement therapy market industry across North America, Europe, Asia, and Rest of World (ROW) A thorough analysis of the market's competitive landscape and detailed information about vendors Comprehensive analysis of factors that will challenge the growth of testosterone replacement therapy market vendors Related Reports: The protein therapeutics market size is estimated to grow at a CAGR of 9.14% between 2022 and 2027. The market size is forecast to increase by USD 153.56 billion. The market is segmented by product (mABs, human insulin, erythropoietin, clotting factors, and others), application (metabolic disorders, immunologic disorders, hematological disorders, cancer, and genetic disorders), and geography (North America, Europe, Asia, and Rest of World (ROW)). The cardiovascular therapeutics market size is estimated to grow at a CAGR of 7.32% between 2022 and 2027. The cardiovascular therapeutics market size is forecast to increase by USD 37.77 billion. The market is segmented by type (antithrombotic drugs, hypolipidemic drugs, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and geography (Asia, North America, Europe, and Rest of World). Testosterone Replacement Therapy Market Scope Report Coverage Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global Testosterone Replacement Therapy Market 2017 - 2021 Exhibit 18: Historic Market Size – Data Table on Global Testosterone Replacement Therapy Market 2017 - 2021 ($ million) 4.2 Distribution Channel Segment Analysis 2017 - 2021 Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million) 4.3 Product Segment Analysis 2017 - 2021 Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million) 4.4 Geography Segment Analysis 2017 - 2021 Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million) 4.5 Country Segment Analysis 2017 - 2021 Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million) 5 Five Forces Analysis 6 Market Segmentation by Distribution Channel 6.1 Market segments Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%) 6.2 Comparison by Distribution Channel Exhibit 32: Chart on Comparison by Distribution Channel Exhibit 33: Data Table on Comparison by Distribution Channel 6.3 Hospitals - Market size and forecast 2022-2027 Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) 6.4 Retail - Market size and forecast 2022-2027 Exhibit 38: Chart on Retail - Market size and forecast 2022-2027 ($ million) Exhibit 39: Data Table on Retail - Market size and forecast 2022-2027 ($ million) Exhibit 40: Chart on Retail - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Retail - Year-over-year growth 2022-2027 (%) 6.5 Online - Market size and forecast 2022-2027 Exhibit 42: Chart on Online - Market size and forecast 2022-2027 ($ million) Exhibit 43: Data Table on Online - Market size and forecast 2022-2027 ($ million) Exhibit 44: Chart on Online - Year-over-year growth 2022-2027 (%) Exhibit 45: Data Table on Online - Year-over-year growth 2022-2027 (%) 6.6 Market opportunity by Distribution Channel Exhibit 46: Market opportunity by Distribution Channel ($ million) Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million) 7 Market Segmentation by Product 7.1 Market segments Exhibit 51: Data Table on Comparison by Product 7.3 Injectables - Market size and forecast 2022-2027 Exhibit 52: Chart on Injectables - Market size and forecast 2022-2027 ($ million) Exhibit 53: Data Table on Injectables - Market size and forecast 2022-2027 ($ million) Exhibit 54: Chart on Injectables - Year-over-year growth 2022-2027 (%) Exhibit 55: Data Table on Injectables - Year-over-year growth 2022-2027 (%) 7.4 Topicals - Market size and forecast 2022-2027 Exhibit 56: Chart on Topicals - Market size and forecast 2022-2027 ($ million) Exhibit 57: Data Table on Topicals - Market size and forecast 2022-2027 ($ million) Exhibit 58: Chart on Topicals - Year-over-year growth 2022-2027 (%) Exhibit 59: Data Table on Topicals - Year-over-year growth 2022-2027 (%) 7.5 Others - Market size and forecast 2022-2027 Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million) Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million) Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%) 7.6 Market opportunity by Product Exhibit 64: Market opportunity by Product ($ million) Exhibit 65: Data Table on Market opportunity by Product ($ million) 8 Customer Landscape Exhibit 70: Data Table on Geographic comparison 9.3 North America - Market size and forecast 2022-2027 Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.4 Europe - Market size and forecast 2022-2027 Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 Canada - Market size and forecast 2022-2027 Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%) 9.9 Germany - Market size and forecast 2022-2027 Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.10 UK - Market size and forecast 2022-2027 Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.11 China - Market size and forecast 2022-2027 Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%) Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography Exhibit 107: Market opportunity by geography ($ million) Exhibit 108: Data Tables on Market opportunity by geography ($ million) 10 Drivers, Challenges, and Trends 10.1 Market drivers Exhibit 109: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11.3 Landscape disruption 11.4 Industry risks Exhibit 163: Pfizer Inc. - Product / Service Exhibit 164: Pfizer Inc. - Key news Exhibit 165: Pfizer Inc. - Key offerings 12.16 Sawai Pharmaceutical Co. Ltd. Exhibit 166: Sawai Pharmaceutical Co. Ltd. - Overview Exhibit 167: Sawai Pharmaceutical Co. Ltd. - Business segments Exhibit 168: Sawai Pharmaceutical Co. Ltd. - Key offerings Exhibit 169: Sawai Pharmaceutical Co. Ltd. - Segment focus 12.17 Teva Pharmaceutical Industries Ltd. Exhibit 170: Teva Pharmaceutical Industries Ltd. - Overview Exhibit 171: Teva Pharmaceutical Industries Ltd. - Business segments Exhibit 172: Teva Pharmaceutical Industries Ltd. - Key news Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key offerings Exhibit 174: Teva Pharmaceutical Industries Ltd. - Segment focus 13 Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

Sawai Pharmaceutical Investments

2 Investments

Sawai Pharmaceutical has made 2 investments. Their latest investment was in SUSMED as part of their Series B on September 9, 2020.

CBI Logo

Sawai Pharmaceutical Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/24/2020

Series B

SUSMED

$0.47M

Yes

2

12/28/2006

Corporate Minority - II

Subscribe to see more

Subscribe to see more

10

Date

9/24/2020

12/28/2006

Round

Series B

Corporate Minority - II

Company

SUSMED

Subscribe to see more

Amount

$0.47M

New?

Yes

Subscribe to see more

Co-Investors

Sources

2

10

Sawai Pharmaceutical Portfolio Exits

1 Portfolio Exit

Sawai Pharmaceutical has 1 portfolio exit. Their latest portfolio exit was SUSMED on December 24, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/24/2021

IPO

$99M

Public

1

Date

12/24/2021

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

1

Sawai Pharmaceutical Acquisitions

1 Acquisition

Sawai Pharmaceutical acquired 1 company. Their latest acquisition was Upsher-Smith Laboratories - Generics Business on April 20, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/20/2017

$99M

Acquired Unit

3

Date

4/20/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired Unit

Sources

3

Sawai Pharmaceutical Partners & Customers

2 Partners and customers

Sawai Pharmaceutical has 2 strategic partners and customers. Sawai Pharmaceutical recently partnered with Neurolief on January 1, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

1/28/2021

Licensor

Israel

Neurolief and Sawai Enter into Exclusive Development and Marketing Agreement for Relivion®

TAMPA , Fla. -- -- Neurolief Ltd. , a neurotechnology innovator , today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co. , Ltd. for the development and marketing of Relivion , a non-invasive digital medical device for migraine and depression , in Japan .

2

10/30/2017

Licensor

United Kingdom

Subscribe to see more

Subscribe to see more

10

Date

1/28/2021

10/30/2017

Type

Licensor

Licensor

Business Partner

Country

Israel

United Kingdom

News Snippet

Neurolief and Sawai Enter into Exclusive Development and Marketing Agreement for Relivion®

TAMPA , Fla. -- -- Neurolief Ltd. , a neurotechnology innovator , today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co. , Ltd. for the development and marketing of Relivion , a non-invasive digital medical device for migraine and depression , in Japan .

Subscribe to see more

Subscribe to see more

Sources

2

10

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.